Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pulmonology
•
Lung Transplant
•
Antifibrotic
•
CLAD
Do you use antifibrotics in patients with restrictive allograft syndrome post lung transplant?
Related Questions
How do you approach management of osteoporosis in patients post lung transplant?
How do you approach induction immunosuppression in patients with high PRA undergoing lung transplantation?
Do you routinely perform a pre-extubation bronchoscopy for secretion clearance during the index hospitalization in patients following lung transplantation?
What is the current practice regarding the use of GLP-1 agonists in patients listed for lung transplant and in the post-transplant period?
How do you manage MAT for opioid use disorder in lung transplant patients during the peri/postoperative period?
How do you integrate dd-cfDNA into the evaluation and management of ACR in lung transplant recipients?
Do you consider early belatacept based immunosuppression in lung transplant recipients?
What factors influence your decision to initiate antifungal treatment in asymptomatic lung transplant recipients colonized with Aspergillus?
What is your preferred agent for fungal prophylaxis in a patient post lung transplant with abnormal LFTs?
How would you manage cardiac sarcoid with intolerance/contraindications to methotrexate, azathioprine, and mycophenolate/mycophenolic acid and that has proven refractory to adalimumab and infliximab as determined by PET?
